166 related articles for article (PubMed ID: 24751108)
1. RNA sequencing identifies novel markers of non-small cell lung cancer.
Han SS; Kim WJ; Hong Y; Hong SH; Lee SJ; Ryu DR; Lee W; Cho YH; Lee S; Ryu YJ; Won JY; Rhee H; Park JH; Jang SJ; Lee JS; Choi CM; Lee JC; Lee SD; Oh YM
Lung Cancer; 2014 Jun; 84(3):229-35. PubMed ID: 24751108
[TBL] [Abstract][Full Text] [Related]
2. CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
Chang SC; Lai YC; Chen YC; Wang NK; Wang WS; Lai JI
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e283-e288. PubMed ID: 29124886
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer.
Favorskaya I; Kainov Y; Chemeris G; Komelkov A; Zborovskaya I; Tchevkina E
Tumour Biol; 2014 Oct; 35(10):10295-300. PubMed ID: 25034531
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
5. Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small cell lung cancer.
Wang L; Wang J; Jia E; Liu Z; Ge Q; Zhao X
Clin Biochem; 2020 Sep; 83():65-73. PubMed ID: 32526228
[TBL] [Abstract][Full Text] [Related]
6. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients.
Zhang Q; Hu H; Liu H; Jin J; Zhu P; Wang S; Shen K; Hu Y; Li Z; Zhan P; Zhu S; Fan H; Zhang J; Lv T; Song Y
Biomed Pharmacother; 2018 Sep; 105():204-214. PubMed ID: 29857300
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
8. Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.
Wang J; Song J; Gao Z; Huo X; Zhang Y; Wang W; Qi J; Zheng S
Oncol Rep; 2017 Mar; 37(3):1736-1746. PubMed ID: 28098899
[TBL] [Abstract][Full Text] [Related]
9. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
10. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
11. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
12. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
13. Detection of long-chain non-encoding RNA differential expression in non-small cell lung cancer by microarray analysis and preliminary verification.
Wang Y; Xu G; Chen W; Pan Q; Huang K; Pan J; Zhang W; Chen J
Mol Med Rep; 2015 Mar; 11(3):1925-32. PubMed ID: 25394782
[TBL] [Abstract][Full Text] [Related]
14. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
16. Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer.
Kim DJ; Kim WJ; Lim M; Hong Y; Lee SJ; Hong SH; Heo J; Lee HY; Han SS
J Korean Med Sci; 2018 Jun; 33(26):e178. PubMed ID: 29930489
[TBL] [Abstract][Full Text] [Related]
17. Tumor-educated leukocytes mRNA as a diagnostic biomarker for non-small cell lung cancer.
Niu L; Guo W; Song X; Song X; Xie L
Thorac Cancer; 2021 Mar; 12(6):737-745. PubMed ID: 33474835
[TBL] [Abstract][Full Text] [Related]
18. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
20. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
